Ingevity's revenue for the
three
months ended in Mar. 2026 was MXN4,652 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was MXN22,231 Mil.
Ingevity's Revenue per Share for the
three
months ended in Mar. 2026 was MXN129.23.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN611.66.
Warning Sign:
Ingevity Corp revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Ingevity was -1.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -9.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 5.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Ingevity's highest 3-Year average Revenue per Share Growth Rate was 12.60% per year. The lowest was -9.40% per year. And the median was 4.20% per year.
Ingevity (MEX:NGVT) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Ingevity Revenue Related Terms
Ingevity Revenue Historical Data
* Premium members only.
The historical data trend for Ingevity's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Ingevity's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity Revenue vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's Revenue distribution charts can be found below:
* The bar in red indicates where Ingevity's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN22,231 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ingevity (MEX:NGVT) has a Revenue of MXN22,231 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Ingevity and its competitors.
Is Ingevity's Revenue too high?
Ingevity's current Revenue is MXN22,231 Mil. Overall, Ingevity has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Revenue compare to KWR and MTX?
Ingevity's Revenue of MXN22,231 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Chemicals company?
A good Revenue depends on the Chemicals industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Ingevity and its competitors. Ingevity's current Revenue is MXN22,231 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (MEX:NGVT) has a current Revenue of MXN22,231 Mil. The stock's GF Value™ is MXN875.62, compared to a current price of MXN1,430.00 — trading 63.3% above its estimated fair value. The current Revenue is MXN22,231 Mil. Ingevity's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Ingevity (MEX:NGVT), the current Revenue is MXN22,231 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (MEX:NGVT) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of MXN1,430.00 is trading 63.3% above its estimated GF Value™ of MXN875.62.
Key valuation signals for MEX:NGVT:
Revenue: MXN22,231 Mil
GF Value™: MXN875.62 vs. price of MXN1,430.00 (63.3% above fair value)
No single metric tells the full story. See the MEX:NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score
Get the complete analysis for MEX:NGVT
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NGVT has been successfully added to your 
